Tech Company Financing Transactions

Regenesis Biomedical Funding Round

On 6/6/2011, Regenesis Biomedical secured $5.3 million in Series C financing from Fulcrum Equity Partners, TGAP Ventures and Solstice Capital.

Transaction Overview

Announced On
6/6/2011
Transaction Type
Venture Equity
Amount
$5,300,000
Round
Series C
Investors

Fulcrum Equity Partners (Lead Investor) (Thomas Greer)

TGAP Ventures (Lead Investor) (Jack Ahrens)

Solstice Capital (Harry George)

Proceeds Purpose
The company would use the funding to accelerate the expansion of its sales force and to seek expanded payer sources including Medicare coverage.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5301 N. Pima Rd.
Scottsdale, AZ 85250
USA
Email Address
Overview
Regenesis Biomedical, Inc. developed and markets the Provant Wound Therapy System, the exciting new scientifically proven approach that is redefining the care of soft tissue wounds.
Profile
Regenesis Biomedical LinkedIn Company Profile
Social Media
Regenesis Biomedical Company Twitter Account
Company News
Regenesis Biomedical News
Facebook
Regenesis Biomedical on Facebook
YouTube
Regenesis Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Brooks
  Scott Brooks LinkedIn Profile  Scott Brooks Twitter Account  Scott Brooks News  Scott Brooks on Facebook
Chief Financial Officer
Dennis Genge
  Dennis Genge LinkedIn Profile  Dennis Genge Twitter Account  Dennis Genge News  Dennis Genge on Facebook
VP - Marketing
Scott Robey
  Scott Robey LinkedIn Profile  Scott Robey Twitter Account  Scott Robey News  Scott Robey on Facebook
VP - Sales
Thomas Eisiminger
  Thomas Eisiminger LinkedIn Profile  Thomas Eisiminger Twitter Account  Thomas Eisiminger News  Thomas Eisiminger on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/6/2011: Infineta Systems venture capital transaction
Next: 6/6/2011: Aquantia venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary